Company Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Announces FDA Approval of the Proclaim Elite SCS System, a Patient-Centric, Recharge-Free, Upgradeable and MR-conditional Chronic Pain Treatment Option

[Business Wire] – St. Jude Medical, Inc. , a global medical device company and an international leader in chronic pain therapy development, today announced FDA approval of the new Proclaim™ Elite Spinal Cord . . . → Read More: Company Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Announces FDA Approval of the Proclaim Elite SCS System, a Patient-Centric, Recharge-Free, Upgradeable and MR-conditional Chronic Pain Treatment Option Similar Articles: Stock Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Announces FDA Approval for Industry’s Only MR-Conditional 5-Column Paddle Lead for the Management of Chronic Pain Company Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Announces Second Quarter 2015 Earnings Conference Call Market Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical’s Axium System Found to Provide Superior Pain Relief Over Traditional Spinal Cord Stimulation for the Treatment of Chronic Lower Limb Pain